Search
for
Sort by
Research 271–300 of 1000+
- Chapter 23. Therapeutic Control of Androgen Action
- Epidermal Wnt/beta-catenin signalling promotes dermal adipocyte differentiation during hair follicle morphogenesis and regeneration
- Pilosebaceous Unit (PSU)
- Is dehydroepiandrosterone a hormone?
- Beyond acne: Current aspects of sebaceous gland biology and function
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Skin diseases in consequence of endocrine alterations
- COVID‐19, androgens, and androgenic alopecia
- Skin manifestations of hyperandrogenism: an update
- Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice through upregulation of the RAS/ERK signaling pathway
- Androgen effects on the skin
- The therapeutic use of androgens in women
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- HAIR REGROWTH
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Cycle pilaire et alopécie X chez le chien
- Molecular biology of hair morphogenesis: Development and cycling
- Neurosteroid Synthesis-Mediated Regulation of GABA<sub>A</sub>Receptors: Relevance to the Ovarian Cycle and Stress
- Endocrinology of Transgender Medicine
- Gender differences in skin: A review of the literature
- Extraskeletal actions of vitamin D
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Prolactin delays hair regrowth in mice
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Gender aspects in skin diseases
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Hormonal treatment of acne vulgaris: an update